Soft Tissue Response in Posterior Teeth Adjacent to Interdental Single Implants: A Controlled Randomized Clinical Trial Comparing Intrasulcular vs Trapezoidal Incision

2016 ◽  
pp. 631-641 ◽  
Author(s):  
Paula Girbés-Ballester ◽  
Jose Viña-Almunia ◽  
David Peñarrocha-Oltra ◽  
Miguel Peñarrocha-Diago
Keyword(s):  
Clinical Trial ◽  
Soft Tissue ◽  
Randomized Clinical Trial ◽  
Tissue Response ◽  
Posterior Teeth ◽  
Soft Tissue Response

Comparing the Responses of Osseous Versus Soft-Tissue Metastases of Renal Cell Carcinoma to Receptor Tyrosine Kinase Inhibitors and Immunotherapy

Kidney Cancer ◽  
2020 ◽  
Vol 4 (3) ◽  
pp. 151-158
Author(s):  
Katherine Yuxi Tai ◽  
Jad M. El Abiad ◽  
Carol D. Morris ◽  
Mark Christopher Markowski ◽  
Adam S. Levin
Keyword(s):  
Renal Cell Carcinoma ◽  
Soft Tissue ◽  
Cell Carcinoma ◽  
Receptor Tyrosine Kinase ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Tissue Response ◽  
Bone Response ◽  
Soft Tissue Response ◽  
Receptor Tyrosine Kinase Inhibitors

BACKGROUND: Checkpoint inhibitors and receptor tyrosine kinase inhibitors (RTKIs) have changed the standard of care for metastatic renal cell carcinoma (mRCC). Anecdotal evidence suggests these therapies may be less effective for treating bone than soft-tissue metastases. PURPOSE: We performed a retrospective review evaluating the relative clinical responses in soft-tissue and bone metastases in patients undergoing therapy using RTKIs and anti-programmed death-1 (PD-1) agents for mRCC. METHODS: Of the 2,212 patients in our institutional cancer registry with renal cell carcinoma (1997–2017), 68 (82 disease courses) were identified with measurable bone and soft-tissue metastases treated with RTKIs and/or PD-1s. Extent of metastasis was quantified at the time of therapy initiation (baseline) and at 3 months, 6 months, and 1 year. Changes in disease status were categorized as complete response, partial response, stable, mixed, or progression of disease according to RECIST v1.1 and MD Anderson criteria. These categories were further organized into “response to treatment” or “evidence of progression” to generate a generalized linear effects model with soft-tissue response as the independent variable and bone response as the dependent variable. Alpha = 0.05. RESULTS: Soft-tissue response correlated with bone response at 3 months (76 disease courses, p = 0.005) and 6 months (48 disease courses, p = 0.017). Of the patients with controlled soft-tissue disease, only 14 (19%) and 15 (32%) had progression in bone at 3 and 6 months, respectively. CONCLUSION: Contrary to anecdotal reports, osseous metastases do not appear to respond worse than soft-tissue metastases to treatment with these agents.

Soft Tissue Response After Chin Advancement Using Two Different Genioplasty Techniques

2014 ◽  
Vol 25 (4) ◽  
pp. 1383-1388 ◽  
Author(s):  
Sameh Ahemd Seifeldin ◽  
Maha Shawky ◽  
Saleem M. Hicham Nouman
Keyword(s):  
Soft Tissue ◽  
Tissue Response ◽  
Soft Tissue Response

scholarly journals A literature review on implant abutment and soft tissue response

2016 ◽  
Vol 32 (4) ◽  
pp. 263-273
Author(s):  
Young-Hoon Lee ◽  
Kyung-Ho Ko ◽  
Yoon-Hyuk Huh ◽  
Chan-Jin Park ◽  
Lee-Ra Cho
Keyword(s):  
Soft Tissue ◽  
Literature Review ◽  
Tissue Response ◽  
Implant Abutment ◽  
Soft Tissue Response
Sign in / Sign up

Export Citation Format

Share Document